High levels of VTCN1 have been observed in invasive breast cancer (13), and high tumor cell expression has been linked to disease progression and poor prognosis in renal cell cancer (12), suggesting that VTCN1 promotes tumor invasion. Here, VTCN1 is linked to invasive breast carcinoma.